These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12239460)

  • 21. Antitumor effect of FP3 on a patient-derived tumor tissue xenograft model of rectal carcinoma.
    Bi T; Bi T; Lan H; Hu X; Zhu M; Xu Z; Hu J; Teng L; Jin K
    Hepatogastroenterology; 2013; 60(128):1950-4. PubMed ID: 24719933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.
    Reubi JC; Waser B; Cescato R; Gloor B; Stettler C; Christ E
    J Clin Endocrinol Metab; 2010 May; 95(5):2343-50. PubMed ID: 20228164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.
    Jia WD; Xu GL; Wang W; Wang ZH; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB
    Tohoku J Exp Med; 2009 Jun; 218(2):155-60. PubMed ID: 19478472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
    Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
    Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
    Hoelting T; Duh QY; Clark OH; Herfarth C
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
    Graillon T; Romano D; Defilles C; Saveanu A; Mohamed A; Figarella-Branger D; Roche PH; Fuentes S; Chinot O; Dufour H; Barlier A
    J Neurosurg; 2017 Sep; 127(3):660-669. PubMed ID: 27982767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.
    Jaskula-Sztul R; Xu W; Chen G; Harrison A; Dammalapati A; Nair R; Cheng Y; Gong S; Chen H
    Biomaterials; 2016 Jun; 91():1-10. PubMed ID: 26994874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients.
    Cascinu S; Del Ferro E; Ligi M; Staccioli MP; Giordani P; Catalano V; Agostinelli R; Muretto P; Catalano G
    Cancer Invest; 2001; 19(1):8-12. PubMed ID: 11291560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
    Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
    Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo.
    Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
    Pediatr Res; 1999 Sep; 46(3):328-32. PubMed ID: 10473050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of octreotide on angiogenesis induced by hepatocellular carcinoma in vivo.
    Jia WD; Xu GL; Sun HC; Wang L; Xu RN; Xue Q
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):404-9. PubMed ID: 14599948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of somatostatin analogue octreotide in medulloblastoma in xenograft and cell culture study.
    Hauser P; Hanzély Z; Máthé D; Szabó E; Barna G; Sebestyén A; Jeney A; Schuler D; Fekete G; Garami M
    Pediatr Hematol Oncol; 2009; 26(5):363-74. PubMed ID: 19579083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.